intermittent), duration, and the timing of consumption relative to other factors like meals or exercise
Ongoing research and development efforts, including novel formulations, dual- and triple-agonist therapies, and extended-release oral agents, hold promise for enhancing accessibility, tolerability, and sustained benefits
Not absent, which would be concerning, but manageable
These modifications drastically reduce binding affinity to IGF binding proteins (IGFBPs), resulting in a significantly extended half-life and enhanced biological activity compared to native IGF-1
Mollan SP
The latest research has found that people who go off the meds regain weight and reverse health benefits